富国恒生港股通创新药及医疗保健ETF发起式联接A(020110)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
680,516.58 |
39,552.04 |
26,432.04 |
| 存出保证金 |
155,159.97 |
9,739.36 |
9,000.60 |
| 交易性金融资产 |
585,014,835.89 |
25,388,710.30 |
16,777,736.43 |
| 其中：股票投资 |
- |
- |
- |
| 债券投资 |
36,057,460.89 |
1,517,489.26 |
1,016,902.74 |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
2,349,404.83 |
36,502.13 |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
25,512,008.91 |
153,414.38 |
738,332.13 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
648,195,196.11 |
26,578,725.14 |
18,414,150.11 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
27,007,249.40 |
1,136,937.74 |
782,245.30 |
| 应付证券清算款 |
37.56 |
- |
- |
| 应付赎回款 |
42,334,263.52 |
491,141.41 |
356,300.64 |
| 应付管理人报酬 |
12,637.47 |
510.67 |
456.08 |
| 应付托管费 |
2,527.48 |
102.14 |
91.18 |
| 应付销售服务费 |
77,011.51 |
2,024.27 |
1,070.08 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
1,084,073.97 |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
49,546.89 |
13,000.00 |
6,464.64 |
| 负债合计 |
70,567,347.80 |
1,643,716.23 |
1,146,627.92 |
| 所有者权益 |
| 实收基金 |
456,583,647.38 |
28,675,079.39 |
22,665,172.83 |
| 未分配利润 |
121,044,200.93 |
-3,740,070.48 |
-5,397,650.64 |
| 所有者权益合计 |
577,627,848.31 |
24,935,008.91 |
17,267,522.19 |
| 负债及所有者权益总计 |
648,195,196.11 |
26,578,725.14 |
18,414,150.11 |
微信公众号
证券之星APP
基本资料
